CN103820564B - The composite amplification reagent kit of 25 STRs - Google Patents

The composite amplification reagent kit of 25 STRs Download PDF

Info

Publication number
CN103820564B
CN103820564B CN201410091492.XA CN201410091492A CN103820564B CN 103820564 B CN103820564 B CN 103820564B CN 201410091492 A CN201410091492 A CN 201410091492A CN 103820564 B CN103820564 B CN 103820564B
Authority
CN
China
Prior art keywords
locus
primer
group
amplification
composite amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410091492.XA
Other languages
Chinese (zh)
Other versions
CN103820564A (en
Inventor
张威
张琰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DINGSHENG TECHNOLOGY (BEIJING) Co Ltd
Original Assignee
DINGSHENG TECHNOLOGY (BEIJING) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DINGSHENG TECHNOLOGY (BEIJING) Co Ltd filed Critical DINGSHENG TECHNOLOGY (BEIJING) Co Ltd
Priority to CN201410091492.XA priority Critical patent/CN103820564B/en
Publication of CN103820564A publication Critical patent/CN103820564A/en
Application granted granted Critical
Publication of CN103820564B publication Critical patent/CN103820564B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of composite amplification system simultaneously analyzing multiple str locus seat, it is characterised in that: 25 locus of composite amplification: Amelogenin, vWA, D10S1248, D2S441, D21S11, D18S51, D5S818, D7S820, D13S317, D16S539, FGA, D2S1338, D22S1045, D1S1656, D19S433, D6S1043, D12S391, D8S1179, D3S1358, CSF1PO, Penta D, Penta E, TH01, TPOX and DYS391.The invention still further relates to analyze method and the test kit of DNA sample, and their purposes simultaneously.

Description

The composite amplification reagent kit of 25 STRs
Technical field:
The present invention relates to biological technical field.Further, the present invention relates to detect in human genome that there is polymorphism Genetic marker gene.The present invention be more particularly directed in an amplification system, expand multiple short series connection with polymerase chain reaction simultaneously Duplicate loci.
Background technology:
STR (being called for short STR) also referred to as microsatellite or simple sequence repeats (SSR), be that a class is widely present Strand of dna connection repetitive sequence in eukaryotic gene group, core sequence is 2-6 base recurring unit.Str locus seat quantity Greatly, branch is extensive, accounts for 3% (Intemational Human Genome Sequencing of whole genome Consortium, 2001), and polymorphism is high, and its polymorphism is derived mainly from core sequence number of repetition difference between individuality, And this species diversity follows mendelian inheritance in genetic process.Therefore, STR augmentation detection technology is widely used in individuality Identify, relationship is identified and population genetic study.
STR composite amplification technology is legal medical expert's individuality identification and the technical way of paternity test at present, all over the world DNA laboratory be used widely (" Forensic DNA Typing " second edition, John Butler).On record Part analysis is used widely, provides strong evidence for cracking of cases.Along with development, a lot of countries utilize this technology to set up The DNA data base of offender and suspect, namely to the DNA data analysis of convict under detention and suspect and be entered into In data base, it is simple to compare and the work such as investigation.
STR composite amplification technology in early days is capable of in a reaction system str locus seat of amplification about 10, Along with the extensive of application and the increase of comparing, the information of 10 locus offers can not meet requirement, producer both domestic and external The product of the more limited loci that exploitation makes new advances, the AmpFISTR Identifiler test kit of such as American AB I company and the U.S. Promega company16 test kits are all that 15 str locus seats add sex determining gene.Domestic also have class As product, the such as Ministry of Public Security two DNATyper15 can realize 15 locus amplifications (DNATyper15 genes simultaneously The research of seat and selection, Ye Jian etc., " Forensic Science ", 2007 03).
But, increasingly wider as the application of identification of means recently as DNA, user's locus number to test kit Amount, information content and proliferation time have had higher requirement.In terms of DNA database establishment, test kit compatibility is also carried Go out new requirement.Having about 2,000,000 parts in the current DNA data base of China, China will enter one in terms of DNA database establishment Step is accelerated, and the data in DNA data base in 2013 will there are about accounting in the data base of the developed countries such as Britain more than 10,000,000 parts The data of total population 10% (Http:// www.forensic.gov.uk.Asplen,2004).Along with China DNA data base builds If scale will constantly expand, the effect of comparing is more and more important.Comparing is built upon STR composite amplification analysis and obtains Data basis on, need each STR test kit have on gene locus compatibility (forensic DNA database in Chian, " Chinese law medical journal ", Jiang Xianhua, the 5th phase of volume 12 in 2006).
13 core gene seats that currently used test kit specifies with the CODIS standard of the U.S. mostly (vWA, D21S11、D18S51、D5S818、D7S820、D13S317、D16S539、FGA、D8S1179、D3S1358、CSF1PO、THO1、 TPOX), based on, at this, basis simply selects to increase other locus, during also portioned product deletes 13 core sequences Portion gene seat.But be as user to locus quantity, information content and the compatibility of test kit higher demand, each factory Business is proposed to be had more site and meets the test kit in up-to-date CODIS site.Each manufacturer test kit locus information is shown in Table 1. So, if using the STR test kit of different manufacturer, importing to the data in DNA data base has locus difference.This Sample is comparison when, and not all data are all effective, and simply the data of homologous genes seating portion can be with comparison, and different portion Divide and just cannot apply.Such as, Identifiler test kit andBetween 16 test kits, identical str locus seat is 13, other two str locus seats are not owing to difference is so acting on when comparing.Further, these 13 can comparison gene Seat data are reliable when of being used for getting rid of, but the most inadequate in the case of assert.Need more gene Seat data.So, owing to each STR test kit locus is different, result in the waste of DNA data base's part data resource, and have Effect property is inadequate.
Along with STR detection kit is more and more extensive in the application of client unit, rapid amplifying is also that test kit performance carries The aspect risen, faster amplification rate greatly reduces the waste of time cost, improves work efficiency.Traditional reagent Box proliferation time was at about 3 to 4 hours, and our company's previous generation Goldeneye20A test kit proliferation time is also left at 2.5 hours Right.If an amplified reaction is completed in realizing 1 hour, the performance of test kit can be greatly promoted, also can improve work efficiency.
Therefore, DNA identifies that field needs to have a reaction and expands more limited loci, is provided that more information amount, has The most compatible and faster amplification rate STR composite amplification body.If able to realized primary first-order equation amplification 25 in one hour Individual above locus, is possible not only to save reagent cost, it is also possible to improves work efficiency, save human cost etc..
Table 1: the gene locus information of each main flow manufacturer's test kit
Note: black font represents CODIS13 gene locus ,+represent the locus being included ,-represent base not to be covered Because of seat
Summary of the invention:
The present invention be directed to the demand, initially set up the composite amplification system of 25 str locus seats of one-time detection, this A little str locus seats contain the full gene seat that each manufacturer is used the most both at home and abroad.
Described locus is Amelogenin, vWA, D10S1248, D2S441, D21S11, D18S51, D5S818, D7S820、D13S317、D16S539、FGA、D2S1338、D22S1045、D1S1656、D19S433、D6S1043、D12S391、 D8S1179, D3S1358, CSF1PO, Penta D, Penta E, TH01, TPOX and DYS391.
The amplification system of the present invention comprises primer mixture, reaction buffer and thermal starting Taq archaeal dna polymerase etc..
Specific primer is separately designed at the flank of its repetitive sequence first against above-mentioned 25 locus.Design of primers is adopted Primer5 software, every primer annealing temperature is used to be close to or higher than 60 DEG C.Primer dimer, other interaction can not be produced Or cross reaction, amplified production length is between 90-480bp.Every pair of primer is carried out amplification assay and optimizes, until obtaining clear Clear single amplified band.Primer sequence see table 2.
Table 2 composite amplification system each locus primer sequence
According to expanding fragment length etc., said gene seat is divided into 4 groups, first group comprise D22S1045, TPOX, D13S317, D7S820, D1S1656, Penta E and D10S1248, second group comprise D8S1179, D5S818, D19S433, D16S539, CSF1PO and Penta D, the 3rd group comprises D3S1358, vWA, D2S1338, D18S51, D6S1043 and D2S441, 4th group comprises Amelogenin, TH01, D12S391, D21S11, FGA and DYS391.Often organize respectively by different fluorescein marks Note, often among group, each locus amplifications product separates according to difference in length, and two locus can not have overlap.Respectively often group is drawn Thing carries out composite amplification test.After determining the situations such as this group does not has non-specific amplification phenomenon, no cross reaction, adjust every pair of primer Concentration, make each fragment peak equalization in group reach more than 40%.
By 4 groups of primers respectively with blue, green, yellow and red fluorescence element labelling.One chain of a labelling in every pair of primer, It is marked at 5 ' ends of primer.Blue markings may select 5-FAM (CF), 6-FAM (6-CF 5(6)-Carboxyfluorescein) or close The fluorescein molecule of spectrum, Green Marker may select HEX (chlordene-6-methyl fluorescein), JOE (6-carboxyl-4,5-bis-chloro-2, 7-dimethoxyfluorescein succinimide ester) or the fluorescein molecule of close spectrum, yellow flag may select TMR (4-methyl- 6-carboxy-rhodamine) or the fluorescein molecule of close spectrum, red-label may select ROX (carboxy-X-rhodamine) or phase dipped beam The fluorescein molecule of spectrum.By 4 groups of 25 locus composite amplifications, adjust each locus primer concentration according to product peak height situation, Each locus peak value entirety harmony is made to reach more than 30%.It is multiple that the primer mixture obtained may be used for above-mentioned 25 locus Close amplification.
The pcr amplification reaction of the present invention can be carried out in certain buffer system.Buffer system includes: 50mM KCI, 10mM Tris-HC1 (PH8.3,25 DEG C), 2.0mM MgCl2, 0.1mg/ml BSA's (bovine serum albumin) and each 0.2mM dNTP.DNTP is four kinds of deoxyribonucleotide (dATP, dTTP, dCTP, dGTP) equimolar mixture.
Taq archaeal dna polymerase needed for reaction is thermal starting archaeal dna polymerase, and antibody is closed and modified or all may be used of chemical modification With.Each amplification system (25 μ 1) of the present invention needs the Taq archaeal dna polymerase of 2U to 4U.
Amplification system on various reaction heat circulating instruments (such as ABI9700, ABI9600, ABI2720, Bio-Rad ICycler, Bio-Rad C1000 etc.) use following program can obtain preferable result: 96 DEG C are incubated 2 minutes;98 DEG C of guarantors Temperature 2 seconds, 60 DEG C are incubated 40 seconds, and 68 DEG C are incubated 20 seconds, and this step runs 30 circulations;4-10 DEG C of insulation.
Template DNA in the present invention is human genome DNA.By various conventional methods, such as paramagnetic particle method, phenol chloroform method, The template DNA that the methods such as resin purification (" Molecular Cloning: A Laboratory handbook " third edition, Cold Spring Harbor Publications) are extracted all can obtain Preferably result.DNA can be prepared by with undertissue or cell: blood (ecchymosis), seminal fluid (seminal stain), skeleton, hair, saliva (salivary stain), perspiration, amniotic fluid etc. containing fetal cell.DNA profiling amount preferably can obtain in the range of 0.25ng to 4ng Preferably amplification, template amount is the lowest may cause the inspection of some gene locus not measure, and the highest meeting of template amount causes non-specific Property amplified production produce.
According to the response procedures amplification template DNA specified in above-mentioned reaction buffer system, each locus can be obtained and mix The amplified production closed.Due to the fact that and have employed fluorescently-labeled primer, amplified production is also with fluorescent marker, and labelling Thing can send under laser excitation and can pass through sequenator (such as ABI377,310DNA sequencer) or genetic analyzer The optical signal that (such as ABI3130,3100genetic analyzer) identifies, so amplified production can pass through sequenator or heredity Carry out electrophoresis on the instruments such as analyser and detection is analyzed.
The when that sequenator or genetic analyzer detecting, amplified production and molecular weight internal standard (marker, Intemal lane standard), Methanamide mix according to a certain percentage, enter in instrument capillary tube or gel and be separated by electrophoresis. Molecular weight internal standard is made up of the fluorescent label DNA fragment of a plurality of known length, is used for calculating pcr amplification product fragment length, Such that it is able to judge gene type and with allelic ladder comparison.
Data after electrophoresis can be analyzed in the data analysis software such as GeneMapper, GeneMarker, GeneScan, Obtain str locus typing collection of illustrative plates and data.
The present invention relates to
(1) a kind of composite amplification system simultaneously analyzing multiple str locus seat, it is characterised in that: 25 bases of composite amplification Because of seat: Amelogenin, vWA, D10S1248, D2S441, D21S11, D18S51, D5S818, D7S820, D13S317, D16S539、FGA、D2S1338、D22S1045、D1S1656、D19S433、D6S1043、D12S391、D8S1179、D3S1358、 CSF1PO, Penta D, Penta E, TH01, TPOX and DYS391.
(2) composite amplification system of the present invention, wherein said locus is divided into following combination: first group is D13S317, TPOX, D22S1045, D7S820, D1S1656, Penta E and D10S1248;Second group be D8S1179, D5S818, D19S433, D16S539, CSF1PO and Penta D;3rd group be D3S1358, vWA, D2S1338, D18S51, D6S1043 and D2S441;4th group is Amelogenin, TH01, D12S391, D21S11, FGA and DYS391, wherein, and amplification Primer first group be SEQ ID NO:1-14;Second group is SEQ ID NO:15-26;3rd group is SEQ ID NO:27-38; 4th group is SEQ ID NO:39-50.
(3) according to the composite amplification system described in item 2, wherein in a composite amplification reaction system, expand 25 simultaneously Locus.
(4) according to the composite amplification system described in item 2, wherein locus is expanded by the pair of primers being positioned at these locus both sides Increase, wherein every pair of primer has 5 ' ends of a primer to carry out fluorescein labelling.
(5) according to the composite amplification system described in item 1, wherein composite amplification multiple str locus seat is to utilize polymerase chain Formula reaction is carried out.
(6) according to the composite amplification system described in item 2, wherein this system comprises primer mixture.
(7) a kind of method simultaneously analyzing DNA sample, it is characterised in that apply the composite amplification system of any of the above-described to examine Survey DNA.
(8) according to the method described in item 7, wherein DNA sample includes blood, ecchymosis, seminal fluid, seminal stain, skeleton, hair, saliva In liquid, salivary stain, perspiration and amniotic fluid one or more..
(9) primer sequence for composite amplification system shown in SEQ ID NO:1-50 or the mixing of described primer sequence Thing.
(10) a kind of test kit for analyzing multiple str locus seat simultaneously, described locus is Amelogenin, vWA, D10S1248、D2S441、D21S11、D18S51、D5S818、D7S820、D13S317、D16S539、FGA、D2S1338、 D22S1045、D1S1656、D19S433、D6S1043、D12S391、D8S1179、D3S1358、CSF1PO、Penta D、Penta E, TH01, TPOX and DYS391, this test kit comprises the primer shown in SEQ ID NO:1-50.
The present invention also provides for having selected from the primer sequence described in table 2, wherein one or more, preferably 1-15, excellent Select 1-10, the modified sequence that preferably 1-5 nucleotide is replaced, deletes and/or adds and obtains.
The invention still further relates to the primer sequence mixture for composite amplification system shown in table 2.
The invention still further relates to above-mentioned primer sequence, test kit and/or composite amplification system be used for analyzing multiple str locus The purposes of seat.
Use the present invention have only to one-time detection, operating time, detection time and detectable cost all reduce 50% or More.The present invention is used to have the highest compatibility, the problem of data compatibility before using the present invention not worry.
Accompanying drawing explanation
Fig. 1-1 and Fig. 1-2 be DNA sample use the present invention amplification after analyze collection of illustrative plates two parts, the right of Fig. 1-1 with There is overlap on the left side of Fig. 1-2, and both can be the collection of illustrative plates that a width is complete with split.
Fig. 2-1 and Fig. 2-2 uses the analysis chart after the Goldeneye20A test kit amplification of basic point cognition company for DNA sample Two parts of spectrum, the right of Fig. 2-1 has overlapping with the left side of Fig. 2-2, and both can be the collection of illustrative plates that a width is complete with split.
Detailed description of the invention
The present invention is further illustrated below by the mode of embodiment.The mesh that the following examples are merely to illustrate that , and and unrestricted the scope of the present invention.
25 gene locus of embodiment 1 composite amplification also analyze its genotype
Blood is contributed by volunteer.Template DNA is extracted by chelex-100 method by blood, separately adds legal medical expert's typing standard Product 9948.Amplified reaction is carried out on ABI9700 thermal cycler, and electrophoresis and detection are carried out on ABI3100 genetic analyzer, number GeneMapper ID v3.2 software is used according to analyzing.Sample uses the SinoFiler test kit of ABI company and basic point to recognize simultaneously Knowing the Goldeneye20A test kit detection of company, operational approach is carried out according to test kit description, and result is as comparison.This Bright reagent used and material such as allelic ladder (ladder) are the conventional material that those skilled in the art commonly use.
1.1.chelex-100 method extracts DNA (concrete grammar reference " Forensic DNA Protocol ", Humana Press, 1998)
1) take 3 μ l and add the blood of anticoagulant in 500 μ l centrifuge tubes
2) vibration mixing chelex solution, makes chelex fully suspend, and often pipe adds the chelex-100 (100-of 195 μ l5% 200mesh, purchased from Bio-Rad company), add 5 μ l E.C. 3.4.21.64s (20mg/ml, purchased from Tian Gen biochemical technology company limited)
3) oscillation sample, after 56 DEG C of temperature are bathed 2 hours on constant-temperature metal bath, takes out sample and vibrates 2 minutes,
4) boiling 8-10 minute, 13000rpm is centrifuged 3 minutes
5) careful sucking-off about 150 μ l supernatant, is transferred in new pipe, and 10 μ l PCR reaction systems take 1 μ l as template
1.2. polymerase chain reaction (PCR) amplification
1) taking buffer, primer mixture, Taq enzyme, be made into mixed liquor according to following table, after vibration mixing, subpackage is anti-to PCR Ying Guanzhong, often pipe 25 μ l, add template DNA
2) thermal cycler is set according to following reaction condition and increases instrument (ABI9700PCR instrument), PCR reaction tube is put into instrument Device starts amplification gene fragment.96 DEG C are incubated 2 minutes;98 DEG C are incubated 2 seconds, and 60 DEG C are incubated 40 seconds, and 68 DEG C are incubated 20 seconds Clock, runs 30 circulations;4 DEG C are persistently incubated, until taking out sample
1.3., after amplified reaction terminates, take out reaction tube, carry out electrophoresis and detection with ABI3100 genetic analyzer
1) take (0.5 μ l molecular weight internal standard+10 μ l deionized formamide) × (sample number) and be made into mixed liquor
2) subpackage, often pipe 10 μ l after mixing, then it is separately added into 1 μ l amplified production and allelic ladder (ladder), letter Liquid is collected centrifuge tube tube bottom by short being centrifuged
3) 95 DEG C of degeneration of sample 4 minutes, then rapid cooled on ice 4 minutes, make the complete degeneration of DNA and keep degeneration shape State
4) sample is put in the sample tray of Genetic Analyser, instrument parameter (sample introduction voltage 3kV, sample injection time are set 10 seconds), start electrophoresis detection
5) after about 40 minutes, electrophoresis terminates, and obtains collection of illustrative plates and typing knot by GeneMapper software analysis experimental data Really (see Fig. 1-1, Fig. 1-2, Fig. 2-1, Fig. 2-2 and table 3)
3 two kinds of test kits of table expand the genotypic results of same sample
Invention effect:
Along with the increase of complex locus number, due to the impact of competition, the relative equilibrium of each locus controls difficulty and adds Greatly, the present invention, by experiment repeatedly, has initially set up the composite amplification system of 25 str locus seats of one-time detection, these STR Locus incorporates most gene locus that each manufacturer is used the most both at home and abroad.Utilize this amplification system permissible Disposable 25 locus: Amelogenin of detection, vWA, D10S1248, D2S441, D21S11, D18S51, D5S818, D7S820、D13S317、D16S539、FGA、D2S1338、D22S1045、D1S1656、D19S433、D6S1043、D12S391、 D8S1179, D3S1358, CSF1PO, Penta D, Penta E, TH01, TPOX and DYS391.
Utilizing this system can obtain 25 locus information with once-through operation, therefore this system has the highest individual knowledge Not rate, is equivalent to the information summation simultaneously utilizing 2-3 other like products to obtain, no matter at PCR amplification and genetic analyzer Detection, all provides cost savings and manpower, improves work efficiency.In amplification link, will be with first two or 3 kinds of test kits Amplification is reduced to the amplification of a kind of test kit, has saved the reagent cost of more than 50%, and the time shortens 50%.Detection, uses 2 kinds or 3 kinds of test kits need sample detection respectively, use the present invention to have only to one-time detection, operating time, detection time and inspection Test agent cost all reduces 50% or more.
The present invention is used to have the highest compatibility, the problem of data compatibility before using the present invention not worry.By Contain the full gene seat of main product that is the most domestic and that use before in these 25 locus, there is good compatibility Property, can not only existing total data in compatible China DNA data base at present, and new generation product is also had the highest holding concurrently Capacitive.
It is understood that above description is only the example of the present invention, thus the model that the claims in the present invention are protected Enclose and not merely limit with particular disclosed herein.The embodiment of any equivalent will be considered the present invention's Within the scope of.It is true that according to description above, the present invention is carried out relevant modifications and variations for those skilled in the art From the point of view of will be all possible, thus, this modifications and variations also will fall within the scope of appended claims of the invention.

Claims (4)

1. analyze a composite amplification method for multiple str locus seat, its diagnosis being not used in disease and treatment, its feature simultaneously It is:
Expand 25 locus in a composite amplification reaction system simultaneously, 25 locus: Amelogenin of composite amplification, vWA、D10S1248、D2S441、D21S11、D18S51、D5S818、D7S820、D13S317、D16S539、FGA、D2S1338、 D22S1045、D1S1656、D19S433、D6S1043、D12S391、D8S1179、D3S1358、CSF1PO、Penta D、Penta E, TH01, TPOX and DYS391;
Described locus is divided into following four groups:
First group is D13S317, TPOX, D22S1045, D7S820, D1S1656, Penta E and D10S1248;
Second group is D8S1179, D5S818, D19S433, D16S539, CSF1PO and Penta D;
3rd group is D3S1358, vWA, D2S1338, D18S51, D6S1043 and D2S441;
4th group is Amelogenin, TH01, D12S391, D21S11, FGA and DYS391;
Specific primer is separately designed so that each sheet in locus group for the above-mentioned flank being grouped in locus repetitive sequence Section peak equalization reaches more than 40%, and primer is divided into following combination:
First group of primer is shown in SEQ ID NO: 1-14;
Second group of primer is shown in SEQ ID NO: 15-26;
3rd group of primer is shown in SEQ ID NO: 27-38;
4th group of primer is shown in SEQ ID NO: 39-50;Often group primer is respectively by different fluorescein labellings;
Wherein locus is expanded by the pair of primers being positioned at these locus both sides, wherein has the 5 ' of a primer to hold in every pair of primer Carry out fluorescein labelling;By above-mentioned four groups of locus composite amplifications, adjust each locus primer concentration according to product peak height situation, Each locus peak value entirety harmony is made to reach more than 30%;
This composite amplification system is that 25 μ l amplification systems include the mixture of 5 μ l primer SEQ ID1-50,12.5 μ l reaction bufferings The thermal starting Taq archaeal dna polymerase of liquid and 2U~4U;
Described reaction buffer includes: 50mM KCl, 10mM Tris-HCl, 2.0mM MgCl2, 0.1mg/ml bovine serum albumin DNTP with 0.2mM.
Composite amplification method the most according to claim 1, it is characterised in that use following procedure to carry out:
1) template DNA is made;
2) polymerase chain reaction (PCR) amplification,
Every 25 μ l amplification systems are made into mixed liquor, and after mixing, subpackage is in PCR reaction tube, 2.5 μ l template DNAs is added PCR anti- Ying Guanzhong;
Thermal cycler is set according to following reaction condition, PCR reaction tube is put into beginning amplification gene fragment in thermal cycler, 95 DEG C are incubated 11 minutes;94 DEG C are incubated 30 seconds, and 60 DEG C are incubated 60 seconds, and 70 DEG C are incubated 60 seconds, run 30 circulations;60℃ It is incubated 30 minutes;4 DEG C are persistently incubated until taking out sample;
3) electrophoresis, detection
Take 0.5 μ l molecular weight internal standard and 10 μ l deionized formamides, be multiplied by sample number, be made into mixed liquor;
1 μ l amplified production and ladder is added, the centrifugal bottom that liquid is collected centrifuge tube with often pipe 10 μ l mixed liquor;
95 DEG C of degeneration of sample 4 minutes, then rapid cooled on ice 4 minutes, make the complete degeneration of DNA and keep denatured state;
Sample is placed in Genetic Analyser beginning electrophoresis detection;
Electrophoresis terminates, and analyzes experimental data and obtains collection of illustrative plates and genotypic results.
3. the primer as shown in SEQ ID NO:1-50 for the composite amplification method described in claim 1 or 2 is mixed Compound.
4. the composite amplification reagent of 25 STRs applying composite amplification method described in claim 1 or 2 Box, this test kit comprises the primer shown in SEQ ID NO:1-50, and described primer is for composite amplification locus: Amelogenin、vWA、D10S1248、D2S441、D21S11、D18S51、D5S818、D7S820、D13S317、D16S539、 FGA、D2S1338、D22S1045、D1S1656、D19S433、D6S1043、D12S391、D8S1179、D3S1358、CSF1PO、 Penta D, Penta E, TH01, TPOX and DYS391.
CN201410091492.XA 2014-03-13 2014-03-13 The composite amplification reagent kit of 25 STRs Active CN103820564B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410091492.XA CN103820564B (en) 2014-03-13 2014-03-13 The composite amplification reagent kit of 25 STRs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410091492.XA CN103820564B (en) 2014-03-13 2014-03-13 The composite amplification reagent kit of 25 STRs

Publications (2)

Publication Number Publication Date
CN103820564A CN103820564A (en) 2014-05-28
CN103820564B true CN103820564B (en) 2016-09-14

Family

ID=50755850

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410091492.XA Active CN103820564B (en) 2014-03-13 2014-03-13 The composite amplification reagent kit of 25 STRs

Country Status (1)

Country Link
CN (1) CN103820564B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105368958A (en) * 2015-12-15 2016-03-02 基点认知技术(北京)有限公司 Kit for realizing multiple amplification of 21 short tandem repeats by adopting degenerate primers
CN106011229B (en) * 2016-04-26 2019-08-27 深圳华大法医科技有限公司 The composite amplification systems of 18 STR bit points for people, kit and application thereof
CN106906292A (en) * 2017-03-29 2017-06-30 司法部司法鉴定科学技术研究所 A kind of 22 STR composite amplification methods and its kit
CN116987798A (en) * 2023-09-26 2023-11-03 深圳荻硕贝肯精准医学有限公司 Primer combination, kit and method for detecting short tandem repeat sequence

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101818192B (en) * 2009-08-27 2013-03-20 基点认知技术(北京)有限公司 Compound amplification kit of 20 short tandem repeats
WO2012067901A1 (en) * 2010-11-15 2012-05-24 Life Technologies Corporation Methods and kits for multiplex amplification of short tandem repeat loci
JP2014515926A (en) * 2011-05-12 2014-07-07 ネットバイオ・インコーポレーテッド Methods and compositions for rapid multiplex amplification of STR loci
CN103451311B (en) * 2013-09-24 2016-04-20 无锡中德美联生物技术有限公司 The test kit of the fluorescence labeling composite amplification of analyst's genomic dna 26 locus and using method thereof and application while of a kind of

Also Published As

Publication number Publication date
CN103820564A (en) 2014-05-28

Similar Documents

Publication Publication Date Title
CN101818192B (en) Compound amplification kit of 20 short tandem repeats
CN109750110B (en) Composite amplification kit for 47 human autosomal and Y chromosome loci and application thereof
Fraga et al. Real‐time PCR
Jalali et al. The polymerase chain reaction: PCR, qPCR, and RT-PCR
Thompson et al. An overview of DNA typing methods for human identification: past, present, and future
CN109468384B (en) Composite amplification detection kit for simultaneously detecting 45Y loci
CN107385064B (en) Fluorescence labeling composite amplification kit for simultaneously amplifying human autosomal SNP and STR loci and application thereof
CN104017895A (en) Composite amplification kit for 26 Y chromosome short tandem repeats
CN106834456B (en) Y-STR multiplex amplification detection kit marked by adopting fluorescence marking method and use method thereof
CN105385763B (en) The kit of fluorescence labeling composite amplification that is a kind of while analyzing 24 locus of human gene group DNA and its application
CN103820564B (en) The composite amplification reagent kit of 25 STRs
CN106011229A (en) Composite amplification system for human 18 STR sites, kit and use of composite amplification system and kit
CN105368958A (en) Kit for realizing multiple amplification of 21 short tandem repeats by adopting degenerate primers
CN106906292A (en) A kind of 22 STR composite amplification methods and its kit
CN108060237B (en) Forensic medicine composite detection kit based on 55Y chromosome SNP genetic markers
CN103789414B (en) The composite amplification reagent kit of 17 X chromosome STRs
CN107557475A (en) Composite amplification system, kit for 23 STR bit points of people and application thereof
CN109777861A (en) The loop-mediated isothermal amplification method of mispairing tolerance and application
CN106319079B (en) Method for detecting 22q11.2 copy number loss
CN108517364B (en) Forensic medicine composite detection kit based on 56Y chromosome SNP genetic markers
CN103789413A (en) Multiplex amplification kit of 18 short tandem repeats (STR)
CN114645078B (en) Method and kit for detecting existence or proportion of maternal cells in fetal sample
CN104031983B (en) Composite amplification kit for 20 Y-chromosome short tandem repeats (STR)
CN108642190B (en) Forensic medicine composite detection kit based on 14 autosomal SNP genetic markers
CN113444835A (en) 2019 novel coronavirus N gene detection primer group, constant-temperature fluorescence detection kit and method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant